Apomab: an agonist monoclonal antibody directed against Death Receptor 5/TRAIL-Receptor 2 for use in the treatment of solid tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/18613768

Download in:

View as

General Info

PMID
18613768